"Information wants to be free" (John Gilmore)
University of Regensburg, Bavaria, Germany
BIOETHICS, MEDICAL ETHICS
Scientific Research Center: University of Regensburg, D-93040 Regensburg, Germany
|
GENERAL TEXTS AND INFOS
Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence: a new international initiative.Authors: ANDREW BOTTOMLEY, CHANTAL QUINTEN, CORNEEL COENS, FRANCESCA MARTINELLI, MURIELLE MAUER, JOHN MARINGWA, CHARLES S. CLEELAND, HENNING FLECHTNER, CAROLYN GOTAY, EVA GREIMEL, MADELEINE KING, DAVID OSOBA, MARTIN J.B. TAPHOORN, BRYCE B. REEVE, JOLIE RINGASH, JOSEPH SCHMUCKER-VON KOCH, JOACHIM WEIS.:European Journal of Cancer Care.Volume 18, Issue 2, Date: March 2009, Pages: 105-107
Tagung (Hanns-Seidel-Stiftung): Chancen der Zukunftstechnologien - Fakten und Bewertungsmassstaebe (Conference (Hanns-Seidel-Foundation): The potentials and perspectives of novel technological developments (nanotechnology, biotechnology, information technology) - facts and assessment criteria):This site contains a series of lectures (partly in English) given by Prof. Dr. Peter Fromherz, Director at the Max-Planck-Institute for biochemestry (Department of Membrane- and Neurophysics) in Martinsried (near Munich), Prof. Dr.Dr. Joseph Schmucker-von Koch, University of Regensburg/Deputy Chairman of the Ethics Committee of the Chamber of Medical Authorities in the State of Bavaria (Bayerische Landesaerztekammer), Prof. Dr. Hans-Werner Mewes, Chair of Genomeoriented Bioinformatics at the Technical University Munich/Director of the Institute for Bioinformatics at the Research Center for Health and the Environment (Forschungszentrum für Umwelt und Gesundheit) (GSF) and others. Portale di Bioetica (in Italian)The site "Portale di Bioetica" covers the major areas of current bioethical debate in Italy and on an international level. Congress of the German Society of Plastic Surgery and the German Society of Aesthetic-Plastic Surgery in Heidelberg.September 18-21, 2002. This site gives you the full program of the congress (pdf-files).My
lecture is mentioned on page 9 and 41 of the program. See also "AGENDA". BASIC BIOETHICAL GUIDELINES
Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: This site contains the full text of the European Convention on Human Rights and Biomedicine IMPORTANT !!!: The biopatent law approved on December 3 by Germany's Bundestag (Parliament), limits patent protection on human gene sequences to "disclosed functions" at the time of the patent application. That means that under German law, a patent awarded to a scientist awarded on a human DNA sequence used for a specific function would not cover a second function discovered later by another researcher using the same DNA sequence. This contradicts the intent of the EU Directive to give full patent protection to the discoverer of the human gene sequence, including for new functions discovered later by other scientists using the same gene sequence. However, applicants can skip the stricter German law by directly applying with the European Patent Office in Munich which strictly follows the Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the Legal Protection of Biotechnological Inventions, July 30, 1998. This legal way to skip the German law by applying directly with the European Patent Office caused Dr. Wolfgang Wodarg, a prominent member of the Enquete-Commission of the German Parliament on Ethics and Law in Medicine not to vote in favor of the law during the parliamentary session on Dec 3. As Dr. Wolfgang Wodarg (Social Democratic Party (SPD)) stated in "Anlage 8, Erklärung nach § 31 GO", on page 13710 of the parliamentry protocol (see link):"Im Ergebnis gilt die sinnvolle und richtige Einschränkung des Stoffschutzes daher jetzt nur für die zukünftige Erteilung von Patenten durch deutsche Patentämter, nicht aber für die in Deutschland geltenden Patente, die durch das Europäische Patentamt vergeben wurden und werden. Da über 90 Prozent aller Patente auf Gene und Gensequenzen durch das Europäische Patentamt erteilt werden, bleibt die sinnvolle Einschränkung des Stoffschutzes, die das Umsetzungsgesetz für § 1 des deutschen Patentgesetzes vorsieht, praktisch wirkungslos. Es ist durch einen Umweg über das Europäische Patentamt somit weiterhin möglich, für den Geltungsbereich des deutschen Patentgesetzes unbeschränkte Stoffpatente auf Gene zu erhalten."("As a result the meaningful and correct restriction of the material protection applies therefore now only to the future assignments of patents by German patent offices, not however to patents valid in Germany, which were and will be assigned by the European Patent Office.Since over 90 per cent of all patents on genes and gene sequences are assigned by the European Patent Office, the meaningful restriction of the material protection, which the conversion/compliance law wants to be applied to § 1 of the German Patent Act, remains practically ineffective. It is thus further possible by a detour via the European Patent Office to receive for the area of the legal application of the German Patent Act unrestricted material patents on genes.")
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use:This site contains regularly updated information on the ICH process DIRECTIVE 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use The Directive 2001/20/EC had to be transformed into national law by the European Member States before May 1, 2003 (PDF-file) Empfehlungen zur Planung, Durchführung und Auswertung von Anwendungsbeobachtungen vom 12 November 1998(Recommendations for planning, performing and evaluating observational trials of Nov 12 1998)Bekanntmachung des Bundesinstituts für Arzneimittel und Medizinprodukte(BfArM)(Published by the German Federal Institute for Medicine and medicinal Products) vom 12.11.1998 (only of historical importance. Due to the new legal situation in the context of the EC Directive 2001/20/EC a new version is in the making. A final version will be posted here as soon as it is available. The BfArM has deleted the link to its former recommendations from its website (!)
Verordnung über die Anwendung der Guten Klinischen Praxis bei der Durchführung von klinischen Prüfungen mit Arzneimitteln zur Anwendung am Menschen (GCP-Verordnung – GCP-V), August 12, 2004 This document contains the full text of binding guidelines concerning good clinical practice in clinical trials in accordance with the 12 th law modifying the AMG (German law regulating the use and application of medicines). These guidelines as well as the modification of the AMG were necessary due to the requirements of the European Directive 2001/20/EC 12. Gesetz zur Aenderung des Arzneimittelgesetzes vom 30.Juli 2004(12 th law modifying the AMG (German law regulating the use and application of medicines) This law now meets the requirements of the European Directive 2001/20/EC GUIDELINE ON STRATEGIES TO IDENTIFY AND MITIGATE RISKS FOR FIRST-IN HUMAN CLINICAL TRIALS WITH INVESTIGATIONAL MEDICINAL PRODUCTS This pdf file contains the complete document
International Protection of Human Rights and Economic Activity (Internationaler Schutz der Menschenrechte und Wirtschaftstaetigkeit)Joint Declaration by the German Federal Government,BDI and BDA,DGB, Forum Human Rights and VENRO This link will lead you to the full text (PDF-file) Final report of the Enquete-Commission of the German Parliament (Deutscher Bundestag) "Law and Ethics in Medicine". This link will lead you to the complete text (PDF-file) Opinion of the German National Ethics Committee on "Genetic Diagnostics before and during pregnancy" (Jan 23, 2003).This link will lead you to the complete text (PDF-file).For other opinions of the Ethics Council on numerous ethical issues see Stellungnahmen (Opinions) German Ethics Council: Historical background: The predecessor of the German Ethics Council, the former German "National" Ethics Committee was installed by former(chancellor) Bundeskanzler Gerhard Schroeder personally to advise him on ethical issues to be debated in the field of modern medicine and all its ramifications. Due to this origin the status of the National Ethics Committee could not be compared to the legal status of the National Ethics Committees of France or Italy for instance. Some critics said that the name of this chancellor-founded committee was a misuse of the word "National". There was a lot of criticism from members of the former Enquete Commission "Law and Ethics in modern medicine" of the German Parliament (Deutsche Bundestag)(15 th session period) concerning establishing an ethical body without parliamentary approval which calls itself "National". The new "German Ethics Council" is now working on the basis of a parliamentary approval. Besides that, the ethical review of clinical trials in Germany is done by ethics committees organized by the respective Landesaerztekammer (chamber of medical authorities) of each federal state or within Medical Faculties. For more information concerning the discussions that took place see the following article in the BERLINER ZEITUNG: Feilschen um den Ethikrat (Bargaining about the Ethics Council)
INTERESTING TO REMEMBER: March 14, 2000 PRESS BRIEFING BY DR. NEAL LANE, DIRECTOR OF THE FORMER(US)PRESIDENT'S (Clinton´s)OFFICE ON SCIENCE AND TECHNOLOGY POLICY AND DR. FRANCIS COLLINS, DIRECTOR OF THE HUMAN GENOME PROJECT: This site shows the
original text of the press conference dealing with very important questions concerning access to and property of the results of human genome research STEMCELL RESEARCH:
European Science Foundation Policy Meeting: Human stem cell research: scientific uncertainties and ethical dilemmas (June 2001) (PDF-file) U.S.House of Representatives: HUMAN CLONING PROHIBITION ACT OF 2003(passed the House of Representatives February 27,2003) This link will lead you to the complete text (PDF-file) Human Cloning Prohibition Act of 2005 (Introduced in Senate) This link will lead you to the complete text ATTACK OF THE CLONES: LEGISLATIVE APPROACHES TO HUMAN CLONING IN THE UNITED STATES Quite an informative article analysing the current legal debate in the US by Adrienne N. Cash THE WHITE HOUSE: REMARKS BY THE PRESIDENT ON STEM CELL RESEARCH, The Bush Ranch, Crawford, Texas This link will lead you to the complete address delivered by the U.S. President George W. Bush on August 9, 2001 Interim Report of the Enquete-Commission of the German Parliament (Deutscher Bundestag) "Law and Ethics in Medicine" on Stem Cell Research This link will lead you to the complete text (PDF-file)
Recommendations of the DEUTSCHE FORSCHUNGSGEMEINSCHAFT /GERMAN SCIENTIFIC RESEARCH ORGANISATION on human STEMCELL RESEARCH: This site shows the full text in German (PDF-files) Criticizing the current legal restrictions for research with human embryonic stemcells in Germany the DEUTSCHE FORSCHUNGSGEMEINSCHAFT /GERMAN SCIENTIFIC RESEARCH ORGANISATION has issued a new statement (dated October 2006) on human STEMCELL RESEARCH in Germany: This site shows the full text in German (PDF-files) Partly in response to the forementioned statement by the Deutsche Forschungsgemeinschaft (DFG)the Federal Association of the Pharmaceutical Industry in Germany (Bundesverband der Pharmazeutischen Industrie) has issued a statement warning of irresponsible promises concerning the availability and use of human embryonic stemcells for therapeutic purposes: This site shows the full text in German (PDF-files)
Speech by the former President of the Federal Republic of Germany JOHANNES RAU concerning the role of human dignity within the life sciences (specifically addressing embryonic stem cell research, preimplantation diagnostics)This link will lead you to the full text in German Protocol 14/214 of the Session of the German Parliament (Deutscher Bundestag) on Jan 30,2002 concerning the import of human embryonic stem cells to Germany This link will lead you to the complete text (PDF-file) Draft for a law concerning the import of human embryonic stem cells to Germany(February 22,2002)(Entwurf eines Gesetzes zur Sicherstellung des Embryonenschutzes im Zusammenhang mit Einfuhr und Verwendung menschlicher embryonaler Stammzellen (Stammzellgesetz – StZG)
This link will lead you to the complete text (Final) Law concerning the import of human embryonic stem cells to Germany(28 June 2002)(Gesetz zur Sicherstellung des Embryonenschutzes im Zusammenhang mit Einfuhr und Verwendung menschlicher embryonaler Stammzellen (Stammzellgesetz – StZG) This link will lead you to the complete text Gesetz zur Aenderung des Stammzellgesetzes vom 14. August 2008 (Law to change the previous stemcell law) This law which entered into force as from 14 August 2008 contains two important changes compared to the previous stemcell law of 28 June 2002: 1) German Researchers are allowed to use stem cells imported to Germany which have been created before 1 May 2007. According to the stem cell law of 2002 they were only allowed to use imported stem cells created before 1 January 2002. 2) German Researchers will not be punished or even put to jail when they use stem cells abroad which they are not allowed to use in Germany. This follows from Article 1, sentence 3 of the new law of 14 August 2008
Statement by 40 Nobel Laureates Regarding Cloning (published on April 10, 2002 by the American Society for Cell Biology) This link will lead you to the complete text United Nations Declaration on Human Cloning, to be found under III. Recommendation of the Sixth Committee, p. 7, 24 Feb 2005 This link will lead you to the complete text of the Declaration press release concerning the United Nations Declaration on Human Cloning reporting also on the voting position of the member statesThis link will lead you to the complete text Protocol 14/233 of the plenary session of the German Parliament which discussed the final draft of the law concerning the import of human embryonic stemcells on April 25,2002. Please note that also a few other subjects were discussed during the plenary session which have therefore been included in the protocol and have nothing to do with the stemcell discussion. The pages dealing with the stemcell discussion are 107-128 and 153-157. This link will lead you to the complete text. (PDF-file)
(German)Law for the Protection of Human Embryos in the Context of Import and Use of Human Embryonic Stemcells (Stemcell Law)("Gesetz zur Sicherstellung des Embryonenschutzes im Zusammenhang mit Einfuhr und Verwendung menschlicher embryonaler Stammzellen; Stammzellgesetz-StZG") This link will lead you to the official text (law effective as of July 01,2002)(PDF-file)
European Commission: survey on opinions from national ethics committees or similar bodies, public debate and national legislation in relation to stem cells OVERVIEW of Opinions from National Ethics Committees or similar bodies, public debate and national legislation in relation to human embryonic stem cell research and use IN EU MEMBER STATES (for Germany see pp.21-25 of the document; National Contact Persons which contributed to the survey: see p.78 where I am also mentioned as national contact person) European Commission: survey on opinions from national ethics committees or similar bodies, public debates and national legislation in relation to stem cells OVERVIEW of Opinions from National Ethics Committees or similar bodies, public debate and national legislation in relation to human embryonic stem cell research and use IN NON-EU MEMBER STATES COMMISSION STAFF WORKING PAPER Report on Human Embryonic Stemcell Research, German VersionThe report has been transmitted to the European Parliament and the Council and will provide the basis for an open and informed debate at the upcoming interinstitutional seminar on 24 April 2003.
PROVISIONAL PRELIMINARY DRAFT OF THE INTERNATIONAL DECLARATION ON HUMAN GENETIC DATA This Provisional Preliminary Draft of the International Declaration on Human Genetic Data has been elaborated by the Drafting Group of the International Bioethics Committee (IBC) for consideration by the IBC at its Tenth session (UNESCO House, 12-14 May 2003). It includes the proposals made by the IBC at its Ninth Session (Montreal, Canada, 26-28 November 2002) and the observations formulated during the Public Hearings Day (Monte-Carlo,Monaco, 28 February 2003). In addition, it takes into account the comments made at the 166th Session of the Executive Board of UNESCO (UNESCO House, 11 April 2003), and it also takes stock of the replies received to the Questionnaire concerning an Outline of this declaration. REPORT ON THE PREPARATION OF AN INTERNATIONAL DECLARATION ON HUMAN GENETIC DATA In accordance with 165 EX/Decision 3.4.2, the Director-General hereby submits this progress report on the work carried out by UNESCO concerning the elaboration of an international declaration on human genetic data. International Declaration on Human Genetic Data, Oct 16, 2003 This document contains the final official text adopted by the General Conference during its 32nd Session in Paris, 29 September to 17 October 2003
WORKING PARTY ON HUMAN GENETICS(CDBI-CO-GT4:Working document on the applications of genetics for health purposes) Working document
on the applications of genetics for health purposes
This working document is made public under the responsibility of the Working Party on Human Genetics (CDBI-CO-GT4). The Council of Europe Steering Committee on Bioethics (CDBI), which agreed with the publication of the document, has not yet examined it. The document therefore does not necessarily reflect the views of the CDBI. It is the outcome of the Working Party's discussions so far on applications of genetics for health purposes, with a view to the elaboration of an additional Protocol to the Convention on Human Rights and Biomedicine.
This document is being made public, together with an explanatory note, to obtain comments from European non-governmental organisations, which will be taken into account for the elaboration of the draft additional Protocol. Comments should be submitted to the Secretariat by e-mail before 30 April 2003 to laurence.lwoff@coe.int or terry.journiac@coe.int.
Comments should be as precise and concise as possible. They should refer to specific provisions in the document or, if appropriate, make proposals for complementary provisions. US SENATE: GENETIC INFORMATION NONDISCRIMATION ACT of 2003This link leads to the full text of the act that passed the US Senate on 14 October 2003 to prohibit discrimination on the basis of genetic information with respect to health insurance and employment.The bill died in the House ! US SENATE: GENETIC INFORMATION NONDISCRIMATION ACT of 2005This link leads to the full text of the act that passed the US Senate(109TH CONGRESS
1ST SESSION S. 306) on Feb 17, 2005 to prohibit discrimination on the basis of genetic information with respect to health insurance and employment.The text of the bill is almost identical with that of the bill of 2003 that died in the House of Representatives ! Finally:The GENETIC INFORMATION NONDISCRIMATION ACT becomes lawThirteen years after it was first
introduced, the Genetic Information Nondiscrimination Act (“GINA”) was signed into law on May 21, 2008 by President Bush. GINA establishes a uniform set of rules against genetic-based discrimination applicable to employers and health
insurers. Opinion of the German Ethics Council ("Nationaler Ethikrat", see link above) on biobanks and genetic data protection. This link leads to the full text which is a valuable basis for further discussions and additional clarifications NEW !!! European Commission: Survey on opinions from National Ethics Committees or similar bodies, public debate and national legislation in relation to human biobanks/EU-countries and Non-EU countries OVERVIEW of Opinions from National Ethics Committees or similar bodies, public debate and national legislation in relation to human biobanks (for Germany see pp.20-23 of the document; National Contact Persons which contributed to the survey: see p.69 where I am also mentioned as national contact person) IMPORTANT JURISDICTION FOR GERMANY: BUNDESGERICHTSHOF (BGH)-Urteil v. 12.01.2005 (judgement as of Jan 12, 2005)concerning the use of genetic data, listed in the court´s acts under AZ: XII ZR 60/03 The Bundesgerichtshof (federal court) has made several important statements concerning the use of genetic data in paragraph 2 c) aa)of the judgement (page 6/7) which are also relevant for the use of genetic data in science. NEW !!!
OECD-website dealing with security issues and the biosciences The Organisation for Economic Cooperation and Development's (OECD) International Futures Program (IFP) has launched a new website dealing with security issues and the biosciences. The website provides a comprehensive information portal for general biosecurity information as well as more focused information on codes of conduct and regulatory oversight mechanisms for the life sciences.
|
e-mail to:
joseph.schmucker-von-koch@gmx.net
University of Regensburg, Institute of Philosophy
Universitaetsstrasse 31
Regensburg, Bavaria 93040
Germany
- Deputy Chairman of the Ethics Committee of the Chamber of Medical Authorities of the State of Bavaria (Bayerische Landesaerztekammer) Bayerische Landesaerztekammer
- member of the European Commission´s (Brussels) Peer Review Board of experts in Bioethics and Medical Ethics
- National Contact Person of the European Commission (Brussels) concerning the ethical debate and legal developments in Germany related to stemcell research, biobanks and xenotransplantation
- Project Consultant to the EORTC (European Organisation for Research and Treatment of Cancer), Brussels, Belgium European Organisation for the Research and Treatment of Cancer EORTC,PROBE project EORTC project advisory board
- Project consultant to the Max-Delbrueck-Center for Molecular Medicine, Berlin (till 2004) Max Delbrueck Center for Molecular Medicine
- member of the Senior Advisory Board of the European College of Liberal Arts (ECLA), Berlin.See List of all Senior Advisory Board Members
- director of the European Academy for Cultural and Scientific Developments
/Engelhardt, Dietrich v. (Medizinische Universität Lübeck): Der Wandel der Vorstellungen von Gesundheit und Krankheit in der Geschichte der Medizin. Passau: Wissenschaftsverlag Rothe 1995 (with an introduction by Joseph Schmucker-von Koch)
/Kampits, Peter(Universität Wien/Wissenschaftliche Landesakademie für Niederösterreich) : Das dialogische Prinzip in der Arzt-Patienten-Beziehung. Passau: Wissenschaftsverlag Rothe 1996 (with an introduction by Joseph Schmucker-von Koch)
/Hartmann, Fritz (Medizinische Hochschule Hannover): Mit der Krankheit leben. Über Lebenswert und Würde chronisch kranker Menschen. Passau: Wissenschaftsverlag Rothe 1996 (with an introduction by Joseph Schmucker-von Koch)
/Baier, Horst (Universität Konstanz): Der Wertewandel im Gesundheitswesen in europäischer Perspektive. Bedingungen und Folgen für die Medizinethik. Passau: Wissenschaftsverlag Rothe 1996 (with an introduction by Joseph Schmucker-von Koch)
/Schipperges, Heinrich (Universität Heidelberg): Lebensqualität und Medizin in der Welt von morgen. Passau: Wissenschaftsverlag Rothe 1996 (with an introduction by Joseph Schmucker-von Koch)
/Schaefer, Hans (Universität Heidelberg): Süssmilchs göttliche Ordnung der Natur - oder: wie lange lebt der Mensch. Passau: Wissenschaftsverlag Rothe 1997 (with an introduction by Joseph Schmucker-von Koch)
/Körtner, Ulrich (Universität Wien): Der unbewältigte Tod. Theologische und ethische Überlegungen zum Lebensende in der heutigen Gesellschaft. Passsau: Wissenschaftsverlag Rothe 1997 (with an introduction by Joseph Schmucker-von Koch)
/Schaefer, Hans (Universität Heidelberg): Die Entstehung von Krankheiten. Passau: Wissenschaftsverlag Rothe 1997 (with an introduction by Joseph Schmucker-von Koch)
/Spitzy, Karl-Hermann (Universität Wien): Ethische Aspekte der Chemotherapie. Passau: Wissenschaftsverlag Rothe 1997 (with an introduction by Joseph Schmucker-von Koch)
/Wuermeling, Hans-Bernhard (Universität Erlangen): Töten oder Sterbenlassen ? Zur Frage der Patientenverfügung. Passau: Wissenschaftsverlag Rothe 1997 (with an introduction by Joseph Schmucker-von Koch)
/Schroeder, Friedrich-Christian (Universität Regensburg): Besondere Strafvorschriften gegen eigenmächtige und fehlerhafte Heilbehandlung ? Passau: Wissenschaftsverlag Rothe 1998 (with an introduction by Joseph Schmucker-von Koch)
/Gerl-Falkovitz, Hanna-Barbara (Technische Universitaet Dresden): Vom "Unterschied der Geschlechter zur "fliessenden Identitaet" ? Darstellung und Kritik feministischer Thesen zur Medizin. Passau: Wissenschaftsverlag Rothe 1998 (with an introduction by Joseph Schmucker-von Koch)
5 new books (Bundesministerin a.D. Prof.Dr. Ursula Lehr, Deutsches Zentrum fuer Alternsforschung, Universitaet Heidelberg, Prof.Dr. Otmar Wassermann, Direktor des Instituts fuer Toxikologie am Klinikum der Universitaet Kiel, Prof.Dr. Dietrich von Engelhardt, Medical University of Lübeck, Dr.Dr.Kai Vogeley, Labor fuer Psychiatrische Hirnforschung, Universitaet Bonn, Prof.Dr. Kai Taeger, Direktor des Instituts fuer Anaesthesiologie, Klinikum der Universitaet Regensburg) are in print.
Also see: Gehlhaar, Sabine S.(Hrsg.): Neuere Beiträge zur Ethik von Medizin und Moderner Biologie, Cuxhaven/Dartfort: Junghans Verlag 1998
Table of contents:
-Joseph Schmucker-von Koch, Regensburg: Der Begriff der Gesundheit im Kontext der Postmoderne. Zur Frage einer rationalen Begründung des Gesundheitsbegriffs.
-Johann S. Ach, Münster: Über die Grenzen der Medizin und den Traum von der Unsterblichkeit
-Christian A. Stadler, Wien: Euthanasie und Menschenwürde - ein rechtsphilosophischer Versuch
-Christof Schorsch, Berlin: Natur, Wissenschaft und Medizin. Medizinphilosophische Betrachtungen
-Freddy Zülicke, Jena: Klonierung: Züchtungsprogramm oder Reproduktionsmedizin ?
-Ze´ev Levy, Haifa: Bioethics - Some Introductory Remarks
Tagung der Hanns-Seidel-Stiftung: Chancen der Zukunftstechnologien - Fakten und Bewertungsmassstaebe (In cooperation with the Hanns-Seidel-Foundation, Conference: The chances of novel technological developments - facts and evaluation criteria)
Samstag, 02. September 2006:
15.30 Uhr Prof.Dr. Peter Fromherz, Max-Planck-Institut fuer Biochemie, Martinsried (Max-Planck-Institute for Biochemistry, Martinsried): Reagenzglas-Experimente zum Hirn-Computer-Interfacing (in-vitro-experiments relating to brain-computer-interfacing) 19.30 Uhr Prof.Dr.Dr. Joseph Schmucker-von Koch, Universitaet Regensburg, Vorsitzender der Expertenkommission fuer Fragen der Ethik in den Biowissenschaften bei der Europaeischen Kommission, Bruessel (University of Regensburg, chairman of the expert commission for ethics in the life sciences of the European Commission,Brussels): Droht der glaeserne Mensch ? Ethische und rechtliche Probleme im Umgang mit genetischen Daten und Biobanken (End of privacy ? Ethical and legal problems concerning the use of genetic data and biobanks)
Sonntag, 03. September 2006
09.30 Uhr Prof.Dr.Hans-Werner Mewes, Lehrstuhl fuer Genomorientierte Bioinformatik, Wissenschaftszentrum Weihenstephan, Technische Universitaet Muenchen (Chair for genome oriented bioinformatics, Science Center Weihenstephan, Technical University Munich): Bioinformatik: Von der Genomsequenz zum Wissensmanagement (From genome sequences to knowledge management) 14.00 Uhr Rainer Beckmann, Mitglied der Enquete-Kommission "Ethik und Recht der modernen Medizin" des Deutschen Bundestags 2000-2005 (member of the Enquete commission "ethics and law in modern medicine" of the German Parliament 2000-2005): Biomedizin ohne Grenzen ? Menschenwuerde im Kontext moderner Medizintechnologien (Biomedicine without limitations ? Human Dignity within the context of modern medical technologies)
Ort (Location): Konferenzzentrum der Hanns-Seidel-Stiftung München (Conference Center), Lazarettstrasse 33 , D-80636 Munich
Researchers, medical professions, industry, academics,NGOs, students and other citizens are invited to actively participate in the citizens' and stakeholders' conference on
"HUMAN GENETIC TESTING, WHAT IMPLICATIONS?"
that the European Commission Directorate "Science and Society" –
"Ethics and Science" is organising in Brussels on 6-7 May 2004. Please see the agenda and register on the website below as soon as possible:
http://europa.eu.int/comm/research/conferences/2004/genetic/index_en.
html
To reach this link easily you can proceed as follows:
+ Select the link
+ Right click
+ Click “open Hyperlink”
One year ago, the European Commission invited a high level Expert Group under the chair of Eryl McNally to draft a report on the ethical, legal and social aspects of human genetic testing in research and healthcare applications.Their 25 recommendations are addressed to practitioners and decision makers at local, national and international level. * Group members will present the recommendations, * well-known specialists will introduce the discussion with their comments * and participants are encouraged to actively engage in the debate.
Please find attached the 25 recommendations in English (copies in other EU languages will be available on the website)
The "ethics and science" team of DG Research, European Commission
Abendseminar: Droht der "gläserne Mensch"? Ethische und rechtliche Probleme im Umgang mit genetischen Daten und Biobanken (End of privacy ? Ethical and legal problems concerning the use of genetic data and biobanks)
Referent: Prof. Dr. Dr.habil. Joseph Schmucker-von Koch, Mitglied der Expertenkommission fuer Fragen der Ethik in den Biowissenschaften bei der Europaeischen Kommission, Bruessel Zeit:Donnerstag, 29. April 2004,
18.30 Uhr Ort:Hanns-Seidel-Stiftung e.V., Bruno-Möhring-Str. 3
12277 Berlin
Grundlagen der Moderne (Programmauszug, Hanns-Seidel-Foundation)
Samstag, den 24.04.2004 09.00 Uhr "Grundcharakter und Entwicklung der neuzeitlichen Naturwissenschaften."
Prof.Dr.Dr.habil. J. Schmucker-von Koch,Praktische Philosophie,Universität Regensburg 15.00 Uhr "Die geistigen Grundlagen unserer Wirtschaftsordnung"
Prof.Dr. Anton Rauscher,Direktor der katholischen sozialwissenschaftlichen Zentralstelle Mönchengladbach
Sonntag, den 25.04.2004 09.00 Uhr "Die geistigen Grundlagen des modernen Staats"
Prof.Dr. Immo Eberl, Geschichtswissenschaftliche Fakultät der
Universität Tübingen Ort: Wildbad Kreuth, 83708 Kreuth
Samstag, 27. März 2004
10.45 Uhr Eröffnung und Begrüßung
Vorstellung der Arbeit der Hanns-Seidel-Stiftung e. V.
Karl Heinz Keil 11.15 bis 12.00 Uhr Grundlagen der Bio- und Gentechnologie: die internationalen Rahmenbedingungen
Dr. Klaus-D. Fascher, Dipl-Biologe,
Bayerisches Staatsministerium für Umwelt, Gesundheit und Verbraucherschutz, München
12.00 Uhr Mittagspause 13.15 bis 14.30 Uhr Fortsetzung der Thematik vom Vormittag
14.30 Uhr Kaffeepause 15.00-16.30 Uhr Humangenomorganisation-HUGO:
Herausforderungen eines internationalen Forschungsverbundes
Prof. Dr. Martin Hrabe de Angelis, GSF-Forschungscentrum für Umwelt und Gesundheit, Institut für Experimentelle Genetik, Neuherberg 16.30 bis 18.00 Uhr Biomedizinische Forschung im internationalen Vergleich Dr.med.vet.Dr.phil.Karin Blumer,Bioethikerin
18.00 Uhr Abendessen Sonntag, 28.März 2004 09.00 bis 11.45 Uhr Droht der gläserne Mensch? Ethische und rechtliche Probleme im
Umgang mit genetischen Daten und Biobanken
Prof. Dr. Dr. Joseph Schmuckcr-von Koch,Universität Regensburg, Institut für Philosophie, Mitglied der Expertenkommission für Ethik in den Biowissenschaftcn bei der Europäischen Kommission 11.45 Uhr Zusammenfassung und Abschlussbesprechung 12.00 Uhr Mittagessen
ORT: Bildungszentrum (Conference Center) Kloster Banz,96231 Bad Staffelstein (between Bamberg and Coburg)
Professor Schmucker von Koch and other Academy Staff are participating in peer group discussions at the following conference:
European Commission, DG Research
Directorate E: Biotechnology, Agriculture and Food
Conference on
Ethical implications of scientific research on bioweapons and prevention of bioterrorism
Brussels, 3 - 4 February 2004
Centre Albert Borchette,
Rue Froissart 36,
Brussels, Belgium
The European Commission, Research DG, Directorate E “Biotechnology, Agriculture and Food”, is organising, in the context of an EC funded research project on “Bioethical Implications of Globalisation” co-ordinated by Prof. E. Mordini, Centre for Science, Society and Citizenship, Rome, a conference on “Ethical Implications of Scientific Research on Bioweapons and Prevention of Bioterrorism” to be held in Brussels on 3-4 February 2004.
The Conference aims to bring together a multidisciplinary group of experts to discuss the ethical implications of scientific research on bioweapons and prevention of bioterrorism including issues such as risk communication, dual use technologies and protection of human subjects.
CONFERENCE ON ETHICAL IMPLICATIONS OF SCIENTIFIC RESEARCH ON BIOWEAPONS AND PREVENTION OF BIOTERRORISM
BRUSSELS, 3-4 February 2004
9.30-10.00 OPENING:
Director Chris Paterman, DG Research,
Director Fernand Sauer, DG SANCO, (to be confirmed)
Prof. Emilio Mordini, Centre for Science, Society and Citizenship, co-ordinator of the EC funded research project on the Bioethical Implications of Globalisation.
10.00-10.30 Keynote address delivered by Mrs. Eryl McNally, Member of the European Parliament
Coffee: 10.30-10.45
11.00-13.30 1st Session: Bioweapons
Chair: Prof. John-Erik Stig Hansen , Statens Serum Institut, Copenhagen
Rapporteur: Dr. Tom Novotny, Institute of global health, USA
Human disease and biodefence research: potential benefits but risks of
misuse.'
Dr. Charles Penn, Centre for Applied Microbiology and Research, Salisbury, UK
Bioweapons against livestocks
Prof. Bartolomeo Biolatti, University of Turin, and Dr. Rosagemma Ciliberti, University of Genoa, Italy
The Science and Security Dilemma
Dr. Patricia S. Wrightson, The National Academies, Washington, DC, USA
Discussion
Lunch 13.30-14.30
14.30- 17.30 2rd Session: Ethics and Policy of Risk Communication
Chair: Prof. Nuri Akkas, Tubitak, Turkey
Rapporteur: Prof. Reidar Lie, University of Bergen, Norway
The “risk society”
Prof. Guido Martinotti, Dept of Sociology, Milan, Italy
Learning to live with risks
Prof. Manfred Green, Israel Centre for Disease Control, Israel
Public Health in Emergencies
Prof. Eric Noji, US Public Health Service, USA
Discussion
4th February 2004
9.00- 11.30 3rd Session: Ethical Implications of Dual Use Technologies
Chair: Prof. Goran Hermeren, Lund University, Sweden, Chair of the European Group on Ethics in Science and New Technologies
Rapporteur: Dr. Fabrizio Fabbri, International society of Doctors for the Environment, Arezzo.
The coexistence between research policy on certain weapons and disarmament.
Dr. Jean Pascal Zanders, Switzerland
Medical journals and dual use technologies
Dr. Philip Campbell, UK
Should genetic information in the Internet be restricted?
Prof. Ruth Chadwick, University of Lancaster, UK
Coffee 11.30-11.45
11.45- 13.00 4th Session: Protection of Human Subjects Involved in Biodefense Research
Chair: Prof. Judith Sandor, Central European University, Budapest
Rapporteur: Prof. Ruth Chadwick, University of Lancaster, UK
Are international ethical codes applicable to classified biomedical research?
Prof. Reidar Lie, University of Bergen, Norway
Clinical trials in biodefense research
Prof. Jean-François Lacronique, Institut de radioprotection et de sûreté nucléaire, Clamart, France
Lunch 13.00-14.00
14.00-16.00 5th Session: General Discussion
Chair: Prof. Stephanie Bird, editor of the Science and engineering Ethics journal, US
Introduction to the discussion by the chairs and rapporteurs.
Conclusions by Prof. Stephanie Bird
16.00 Closing remarks
Prof. E.V. Cosmi, chairman of the Bioethical Commission of the National Research Council, Italy ( to be confirmed)
BUCHER BIOETHISCHER DIALOG
SYMPOSIUM:
Montag, 22.10.2001, 16.00 Uhr Prof.Dr.Dr.Joseph Schmucker-von Koch (Universitaet Regensburg): The Ethics Debate about Stem Cell Research within the European Union - current tendencies and possible solutions - Die Ethik-Debatte zur Stammzellforschung in der EU - aktueller Stand und moegliche Loesungsperspektiven
Montag, 10.09.2001, 19.30 Uhr Prof.Dr.Juergen Mittelstrass (Universitaet Konstanz): Theoretische und ethische Grenzen der Wissenschaft Prof.Dr. Michael Moxter (Universitaet Hamburg): Biologische Forschung als Bewaehrungsprobe modernen Rechts. Anmerkungen zum Vorrang des Rechts vor der Moral
Ort der Vortraege: Seminarraum des Forschungsinstituts fuer Molekulare Pharmakologie (FMP), Robert-Roessle-Strasse 10, Berlin-Buch
Freitag, 02.03.2001
Dr. Heribert Lorenz (Center for Nanoscience, Sektion Physik, Ludwig-Maximilians-Universitaet Muenchen): Nanotechnology- Der Schluessel zum 21. Jahrhundert
Zeit: 19.00 Uhr
Samstag, 03.03.2001
Prof.Dr. Helmut Schmidt (Direktor des Instituts fuer Neue Materialien, Saarbruecken): Nanotechnologie als Chance fuer die Zukunft. Die Rolle der Chemie als Wegbereiter für Nanowerkstoffe
Zeit: 09.00 Uhr
Prof.Dr. Erich Wintermantel (Lehrstuhl und Zentralinstitut fuer Medizintechnik, Technische Universitaet Muenchen): Moderne Biomaterialforschung fuer das Tissue Engineering. Ergebnisse-Maerkte-Entwicklungen
Zeit: 15.00 Uhr
Sonntag, 04.03.2001
Prof.Dr.Dr.habil. Joseph Schmucker-von Koch (Universitaet Regensburg): Ethische Implikationen der nanotechnologischen Entwicklung
Zeit: 09.00 Uhr
Ort aller Veranstaltungen: Bildungszentrum Wildbad Kreuth der Hanns-Seidel-Stiftung
6. NIEDERBAYERISCHE ETHIKTAGUNG in Zusammenarbeit mit der Bayerischen Landesaerztekammer, den Aerztlichen Kreisverbaenden Landshut und Straubing, dem Aerztlichen Bezirksverband Niederbayern sowie der Akademie fuer Ethik in der Medizin (Universitaet Goettingen)
"FOREVER YOUNG" Ewige Jugend, Schönheit und Makellosigkeit - ein Ziel der modernen Medizin ?
Zeit: Samstag, 24. November 2001, Beginn: 09.30 Uhr
Ort: Historischer Rathaussaal, Theresienplatz 20, Straubing
ACHTUNG !!! Die Ethiktagung ist AIP-faehig und es werden 3 Punkte fuer das Fortbildungszertifikat angerechnet !
PROGRAMM:
09.30 Uhr Begruessung und Themeneinfuehrung
Dr. Wolfgang Bomfleur, Aerztlicher Kreisverband Straubing
Dr. Maria E. Fick, Aerztlicher Kreisverband Landshut
09.45 Uhr Prof. Dr. Dr. Joseph Schmucker von Koch (Universitaet Regensburg, Institut fuer Philosophie): Sinn und Fragwuerdigkeit von Utopien der Vollkommenheit in der Medizin)
10.15 Uhr CA Dr. Marita Eisenmann-Klein (Plastische Chirurgie, Caritas-Krankenhaus St. Josef, Regensburg): Die Sehnsucht nach Schoenheit und die Rolle der plastischen Chirurgie
10.45 Uhr Pause
11.15 Uhr Dr. Juergen Bickhardt (Internist und Palliativmediziner, Erding): Alt werden ohne alt zu sein ?
11.45 Uhr PD CA Dr. Gerlinde Debus (Gynaekologie und Geburtshilfe, Krankenhaus Muenchen-Neuperlach): "Lifestyle" und "Anti-Ageing": neue Themen in der Gynaekologie
12.15 Uhr Abschlussdiskussion im Plenum. Moderation: Dr. Maria E. Fick, Aerztlicher Kreisverband Landshut
Wir danken den Firmen AVENTIS, BAXTER-IMMUNO, BETAPHARM Arzneimittel, GÖDECKE-PFIZER, GRÜNENTHAL, HORMOSAN-KWIZDA, ROERIG-PFIZER und SANOFI-SYNTHELABO fuer die freundliche Unterstuetzung
06.07.00 Prof. Detlev Ganten (Max Delbrück Centrum fuer Molekulare Medizin, MDC, Berlin-Buch)
Molecular Analysis of Diseases: The Hypertention Paradigm
14.07.00 Prof. W. Rosenthal (Forschungszentrum für Molekulare Pharmakologie, FMP, Berlin)
Perspectives in Molecular Pharmacology: Implications for Society at Large
20.07.00 Prof. R. Martin (National Institute of Health, NIH, Washington,USA)
From Laboratory Bench to Bedside - Biomedical Research in Multiple Sclerosis
27.07.00 Prof. J. Schmucker von Koch (Universität Regensburg)
Is a value oriented concept of man anachronistic? Sloterdijk´s thoughts on the social
function of biotechnology in the light of current bioethical standards
03.08.00 Prof. R. Moreno Diaz (Instituto Universitario de Ciencias y Tecnologias Ciberneticas Universidad de Las Palmas)
The Art of Modelling Brain Functions
10.08.00 Prof. T. Chase (National Institute of Health, NIH, Washington, USA)
Medical Therapy: Scientific Opportunities and Societal Perils
17.08.00 Prof. Jens Reich (Max Delbrück Centrum fuer Molekulare Medizin, MDC, Berlin-Buch)
Bioinformatics - its strategic role in molecular biology and its medical application
All lectures are given at 19oo at the Festsaal of house 214 Karower Str. 11, Berlin-Buch.
Program Coordinator Life Sciences: Dr. S. Mientus, Universitaetsklinikum Benjamin Franklin, Berlin
-------------------------------------------------- ------------------------------------------------------------
Program of the 16th Congress of the Union of Arab Medical Doctors in Europe (ARABMED), Duesseldorf, 17.-19. September 1999
Schirmherrschaft (Honorary Chairman): Frau Dr.B.Fischer, Gesundheitsministerin des Landes Rheinland Pfalz (Minister of Health in the State of Rheinland Pfalz)
Honorary Speaker: Prof.Dr. I. Shatty, Gesundheitsminister von Syrien (Syrian Minister of Health)
Greetings: Dr. Adnan Turkustani, Saudi Arabia
OPENING SESSION:
Time:16.30-18.00 hrs
Place: Spiegelsaal, Renaissance Hotel
1.
Opening speech by: Dr. H. NAGGAR (President of ARABMED)
Introduction by: Dr. F.O.MAHMOUD (Center of Heart Surgery, University of Erlangen-Nuernberg)
Official Greetings from the Government of the State of Rheinland-Pfalz: Mrs. Dr.B. FISCHER (Minister of Health, Rheinland-Pfalz)
2.
Prof.Dr. I. SHATTY (Minister of Health, Damascus, Syria):
The Health System of Syria
3.
Dr.Adman TURKUSTANI (Saudi Arabia):
The Health System of Saudi Arabia
---
SCIENTIFIC RESEARCH
Time: 18.20-19.50 hrs
Place: Spiegelsaal
Chairman: Prof.Dr. M. YASS, Dr.N. SRADJ
4.
Prof.Dr.Dr.Joseph SCHMUCKER VON KOCH (University of Regensburg/European Academy for Cultural and Social Affairs), Dr.N.SRADJ
Science Policy and Basic Research Programs
5.
Prof.Dr. M. YASS:
Computers in Medicine
6.
Dr.Gamal HAMMAD:
Communication in Medicine
7.
Prof.Dr. M. AL ATTAR:
Communication and the Arabic Language
Round Table Discussion
16 th Congress of the Union of Arab Medical Doctors in Europe: Interdisciplinary and Intercultural Dialogue. Introductory remarks by Prof.Dr.Dr.J.Schmucker von Koch. Published in "Arab Medical Journal" (Arabisches Aerzteblatt) Vol.9, 3/1999
_____________________________________________________________________
A few copies of the proceedings of the following congress are still available (free of charge). Please order by e-mail from: ljw@gmx.net/
Einige Vortrags-Baende des folgenden Kongresses sind kostenlos noch erhaeltlich ueber: ljw@gmx.net
LES ENTRETIENS DE MONACO 1980
CONGRESS: LE ROLE DE LA MEDECINE DANS LA CRISE DU MONDE OCCIDENTAL
Chairmen of the Organizing Committee: Docteur E. REYMOND, Docteur VOSS, Professeur J. SCHMUCKER(-VON KOCH)
The congress took place in the Palais du Congrès.
The organizing committee was cordially received by S.A.S. le Prince Souverain Rainier de Monaco who was then assisted by S.A.S la Princesse Caroline de Monaco.
There was also a banquett taking place in the Palais de Gouvernement for the scientists which was attended by the former French Prime Minister Messmer, and
a reception by S.A.S la Princesse Antoinette of Monaco for all congressmen taking place in the famous Hotel de Paris in Monte Carlo.
The congress set a highlight for future activities.
Summary:
Remerciements (Docteur E.REYMOND, a personal friend of the current French President Jacques Chirac)
Allocution de Son Altesse Sérénissime la Princesse ANTOINETTE DE MONACO
Science, spiritualité, crise. La responsabilité du scientifique. (Professeur LEPRINCE-RINGUET)
Responsabilité de la société dans la démission du malade ( Professeur Jacques ELLUL)
La confiance en soi ( Monsieur le Premier Ministre Pierre MESSMER)
Intervention (Professeur LABORIT)
Orientation (Docteur VOSS)
Le Système de Base de Pischinger et son importance dans l´évolution future de la médecine (Professeur G. KELLNER)
Le Système de Base de Pischinger, une voie pour sortir de la crise de la médecine moderne (Docteur PERGER)
La femme qui travaille et ses difficultés de santé (Professeur M. BLOHMKE)
Le médecin et la mort (Docteur Cl. PERRIN)
A propos des phénomènes parapsychologiques (Professeur LIGNON)
Un nouveau regard sur la thérapeutique: de la pharmacologie à la pharmécologie (Docteur J.M.PELZ, former medical adviser to King Ibn Saud of Saudi Arabia)
La biologie de la connaissance (Docteur VARELLA)
Pour une épistémologie de la médecine (Professeur SCHMUCKER(-VON KOCH))
Point de vue du psycho-somaticien. Psychisme et physique: quelques considérations (Professeur B. LUBAN-PLOZZA)
-------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------
JUST IN: The book containing all the lectures and statements listed in the program below has just been published.
The publication was sponsered by DRESDNER BANK and BANQUE NATIONAL DE PARIS :
University and its Students. International Symposium of Students and Professors (edited by Severin Daum/Tomas Kruta),
650 th anniversary of Charles University. Prague: The Carolinum Press 2000 (ISBN 80-7184-933-2)
Please pay attention to the following information:
UNIVERSITAS CAROLINA PRAGENSIS
650 th ANNIVERSARY
INTERNATIONAL SYMPOSIUM OF STUDENTS AND PROFESSORS
UNIVERSITY AND ITS STUDENTS
PRAGUE, CZECH REPUBLIC
September 9-12, 1998
Under the auspices of the Rector of Charles University
Prof.Dr.K.Maly, D.Sc.
Chairman:
Prof. S. Daum, M.D.
Secretary:
T. Kráta, M.D.
Symposium venue:
Faculty of Law of Charles University
Nám. Curieovych 7
116 40 Prague 1
Czech Republic
Date: September 9-12, 1998
Symposium languages: The official language of the symposium is English.
Several lectures will be presented also in German or French. Simultaneous translation into
English, German, French and Czech will be available.
ORGANIZING COMMITTEE:
CHAIRMAN: S. Daum, Charles University Prague, Technische Universitaet Muenchen
VICE-CHAIRMAN:
V. Havránek, Charles University Prague
J. Pánék, Charles University Prague
I. Wilhelm, Charles University Prague
MEMBERS:
J. Herget, Charles University Prague
A. Hornych, University Paris, France
W. Hromadka, University Passau , Germany
J.Koutécky, Charles University Prague
Z. Lojda, Charles University Prague
J. Schmucker-von Koch, University Regensburg, Germany
Students:
T. Krúta, Charles University Prague
D. Lecian, Charles University Prague
P. Matéjcková, Charles University Prague
J. Roehrich, Charles University Prague
PROGRAM:
WEDNESDAY, September 9, 1998
17.00 Opening ceremony at the Great Aula of Carolinum
18.30 Party by the Rector of Charles University
THURSDAY, September 10, 1998
8.30 Opening Speech/ Z. LOJDA, Prague
8.35 Culture and Civilisation/ W.BARTOSZEWSKI, Warsaw
9.15 Discussion
SECTION I FREEDOM AND RESPONSIBILITY - ROLE OF THE UNIVERSITY AND ITS STUDENTS
9.30 Introduction/Ch. MEIER, Munich
10.00 Discussion
10.15 Coffee break
10.35-12.00 Presentations of students/Free papers
12.00-14.00 Lunch break
14.00 Ethics and Science/W.V. WALLACE, Glasgow
14.25 R.I.Frye, Rochester
14.50 Discussion
SECTION II RELIGION, POLITICS AND SCIENCE
14.55 Introduction/T. HALIK, Prague
15.20 Discussion
15.35 Coffee break
15.50-16.55 Presentations of students/Free papers
16.55 Summary
UNIVERSITY STUDENTS DURING THE HISTORICAL DEVELOPMENT OF THE UNIVERSITY
(CONFESSIONAL, SOCIAL, NATIONAL, AND RACIAL PROBLEMS)
17.00 EUROPE: F. SEIBT, Munich
17.25 USA: A. SCHIRGER, Rochester
17.45 "Cultural" Revolution/D. Wang, Wuhan, People´s Republic of China
18.05 Discussion
18.25 Summary
20.00 Social Evening (DIXIELAND with Prof.J. TICHY)
FRIDAY, SEPTEMBER 11, 1998
8.30 Historical Science: Myth and Reality/Z. YAVETZ. Tel Aviv
9.05 Discussion
SECTION III UNIVERSITY STUDENTS AND SOCIETY - MUTUAL RELATIONS
9.25 Introduction/ E. HOBSBAWM, London
9.45 Discussion
10.00 Coffee break
10.20-11.55 Presentations of students/Free papers
11.55 Summary
12.00-14.00 Lunch break
14.00 Human Rights - the Role of the University and its Students/A. GROSSER, Paris
14.30 Discussion
Section IV FUTURE OF THE UNIVERITY AND ITS STUDENTS AND PROFESSORS
14.45 Introduction/ W. HERRMANN, TECH UNIVERSITY, Munich
15.10 P. Chartier, Paris
15.30 Discussion
15.50 Coffee break
16.10 The University and its Students in the context of Modern Information Technology/J. SCHMUCKER-VON KOCH, Regensburg
16.30 Discussion
16.45-17.45 Presentation of students/Free papers
17.45 Summary
17.50 Closing Ceremony
19.15-20.00 Ecumenic Workshop - University Church St. Salvator/Music of J.S.BACH
20.30 Closing Party
Wallenstein Palace
----------------------------------------------------------------------
----------------------------------------------------------------------
STUDENT-SECTION:
Texts will be added either here or in paper form at the secretariat for the upcoming seminars on bioethics !
Für eine kritische Diskussion/for a critical discussion I´m adding here again(im Rahmen unseres Hauptseminars füge ich
hier die) the "Declaration in Defense of Cloning.." as well as another text which represents the opposite view (sowie einen weiteren Text an, der eine entgegengesetzte Position vertritt):
DECLARATION IN DEFENSE OF CLONING AND THE INTEGRITY OF SCIENTIFIC
RESEARCH
The following declaration is from Free Inquiry magazine, Volume 17, Number 3.
Tuesday, 15 July 1997
We, the undersigned, welcome announcements of major advances in the cloning of higher animals. Throughout this century, the physical, biological, and
behavioral sciences have placed important new capabilities within human reach. On balance, these advances have contributed to enormous improvements in
human welfare. Where novel technologies have raised legitimate ethical questions, the human community has in general demonstrated its willingness to confront
those questions openly and to seek answers that enhance the general welfare.
The cloning of higher animals raises ethical concerns. Appropriate guidelines need to be developed that will prevent abuses, while making the benefits of cloning
maximally available. Such guidelines should respect to the greatest extent possible the autonomy and choice of each individual human being. Every effort should
be made not to block the freedom and integrity of scientific research.
No one has demonstrated a present capability to clone humans. Yet the very possibility that contemporary achievements may open a path toward cloning has
sparked a hail of protests. We view with concern the widespread calls to delay, defund, or discontinue cloning research which have come from sources as
disparate as President Bill Clinton in the United States, President Jacques Chirac of France, former Prime Minister John Major of Great Britain, and the Vatican
in Rome.
We believe that reason is humanity's most powerful tool for untangling the problems that it encounters. But reasoned argument has been a scarce commodity in
the recent flood of attacks on cloning. Critics have delighted in drawing parallels to the myth of Icarus and Mary Shelley's Frankenstein, predicting terrible
consequences if researchers dare to press on with questions whose answers "man was not meant to know." Behind the most vituperative critiques seems to lie the
assumption that human cloning would raise moral issues more profound than those faced in connection with any previous scientific or technological development.
What moral issues would human cloning raise? Some religions teach that human beings are fundamentally different from other mammals - that humans have been
imbued with immortal souls by a deity, giving them a value that cannot be compared to that of other living things. Human nature is held to be unique and sacred.
Scientific advances that pose a perceived risk of altering this "nature" are angrily opposed.
Deeply rooted as such ideas may be in dogma, we question whether these should be used to decide whether human beings will be permitted to benefit from new
biotechnology. As far as the scientific enterprise can determine, Homo sapiens is a member of the animal kingdom. Human capabilities appear to differ in degree,
not in kind, from those found among the higher animals. Humankind's rich repertoire of thoughts, feelings, aspirations, and hopes seems to arise from
electrochemical brain processes, not from an immaterial soul that operates in ways no instrument can discover.
The immediate question raised by the current debate over cloning is, therefore, do advocates of supernatural or spiritual agendas have truly meaningful
qualifications to contribute to that debate? Surely everyone has the right to be heard. But we believe that there is a very real danger that research with enormous
potential benefits may be suppressed solely because it conflicts with some people's religious beliefs. It is important to recognize that similar religious objections
were once raised against autopsies, anesthesia, artificial insemination, and the entire genetic revolution of our day - yet enormous benefits have accrued from each
of these developments. A view of human nature rooted in humanity's mythical past ought not to be our primary criterion for making moral decisions about cloning.
We see no inherent ethical dilemmas in cloning nonhuman higher animals. Nor is it clear to us that future developments in cloning human tissues or even cloning
human beings will create moral predicaments beyond the capacity of human reason to resolve. The moral issues raised by cloning are neither larger nor more
profound than the questions human beings have already faced in regards to such technologies as nuclear energy, recombinant DNA, and computer encryption.
They are simply new.
Historically, the Luddite option, which seeks to turn back the clock and limit or prohibit the application of already existing technologies, has never proven realistic
or productive. The potential benefits of cloning may be so immense that it would be a tragedy if ancient theological scruples should lead to a Luddite rejection of
cloning. We call for continued, responsible development of cloning technologies, and for a broad-based commitment to ensuring that traditionalist and
obscurantist views do not irrelevantly obstruct beneficial scientific developments.
The signers of the Declaration are Humanist Laureates of the International Academy of Humanism:
Pieter Admiraal, Medical Doctor, The Netherlands
Ruben Ardila, psychologist, National University of Colombia, Colombia
Sir Isaiah Berlin, Professor Emeritus of Philosophy, Oxford University, U.K.
Sir Hermann Bondi, Fellow of the Royal Society, Past Master, Churchill College, Cambridge University, U.K.
Vern Bullough, Visiting Professor of Nursing, California State University at Northridge, U.S.A.
Mario Bunge, Professor of Philosophy of Science, McGill University, Canada
Bernard Crick, Professor Emeritus of Politics, Birkbeck College, University of London, U.K.
Francis Crick, Nobel Laureate in Physiology, Salk Institute, U.S.A.
Richard Dawkins, Charles Simionyi Professor of Public Understanding of Science, Oxford University, U.K.
José Delgado, Director, Centro de Estudios Neurobiologicos, Spain
Paul Edwards, Professor of Philosophy, New School for Social Research, U.S.A.
Antony Flew, Professor Emeritus of Philosophy, Reading University, U.K.
Johan Galtung, Professor of Sociology, University of Oslo, Norway
Adolf Grünbaum, Professor of Philosophy, University of Pittsburgh, U.S.A.
Herbert Hauptman, Nobel Laureate, Professor of Biophysical Science, State University of New York at Buffalo, U.S.A.
Alberto Hidalgo Tuñón, President, Sociedad Asturiana de Filosofía, Spain
Sergei Kapitza, Chair, Moscow Institute of Physics and Technology, Russia
Paul Kurtz, Professor Emeritus of Philosophy, State University of New York at Buffalo, U.S.A.
Gerald A. Larue, Professor Emeritus of Archeology and Biblical Studies, University of Southern California at Los Angeles, U.S.A.
Thelma Z. Lavine, Professor of Philosophy, George Mason University, U.S.A.
Jose Leite Lopes, Director, Centro Brasiliero de Pesquisas Fisicas, Brazil
Taslima Nasrin, Author, Physician, Social Critic, Bangladesh
Indumati Parikh, Reformer and Activist, India
Jean-Claude Pecker, Professor Emeritus of Astrophysics, Collège de France, Academy of Sciences, France
W. V. Quine, Professor Emeritus of Philosophy, Harvard University, U.S.A.
J. J. C. Smart, Professor of Philosophy, University of Adelaide, Australia
V. M. Tarkunde, Reformer and Activist, India
Richard Taylor, Professor Emeritus of Philosophy, University of Rochester, U.S.A.
Simone Veil, Former President, European Parliament, France
Kurt Vonnegut, Novelist, U.S.A.
Edward O. Wilson, Professor Emeritus of Sociobiology, Harvard University, U.S.A.
Affiliations listed for identification only.
Tuesday, 15 July 1997, 00:00:00 GMT
David Noelle / admin@SecularHumanism.org
A FINAL WORD TO MY STUDENTS
A somewhat opposite view you will find by clicking the following line:
cloning, reproductive medicine, genetic engineering: Here you will find the text mentioned above. More texts will be added.
END of STUDENT SECTION
"He who doesn´t think will be kicked out", Joseph Beuys said ("Wer nicht denkt, fliegt raus"). "Beware, I´m more tolerant" (Joseph Schmucker von Koch)
--------------------------------------------------------------------
some interesting computer hard and software available (for my US based students only)!
Copyright 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009 J. Schmucker-von Koch. All rights reserved